Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature

Paul Gregorevic, Brian R. Schultz, James M. Allen, Jeffrey B. Halldorson, Michael J. Blankinship, Norman A. Meznarich, Christian S. Kuhr, Caitlin Doremus, Eric Finn, Denny Liggitt, Jeffrey S Chamberlain

Research output: Contribution to journalArticleResearchpeer-review

38 Citations (Scopus)


A growing body of research supports the development of recombinant adeno-associated viral (rAAV) vectors for delivery of gene expression cassettes to striated musculature as a method of treating severe neuromuscular conditions. However, it is unclear whether delivery protocols that achieve extensive gene transfer in mice can be adapted to produce similarly extensive gene transfer in larger mammals and ultimately patients. Consequently, we sought to investigate methodological modifications that would facilitate rAAV-mediated gene transfer to the striated musculature of canines. A simple procedure incorporating acute (i) occlusion of limb blood flow, (ii) exsanguination via compression bandage, and (iii) vector "dwell" time of <20 minutes, markedly enhanced the transduction of limb muscles, compared with a simple bolus limb infusion of vector. A complementary method whereby vector was infused into the jugular vein led to efficient transduction of cardiomyocytes and to a lesser degree the diaphragm. Together these methods can be used to achieve transgene expression in heart, diaphragm, and limb muscles of juvenile dogs using rAAV6 vectors. These results establish that rAAV-mediated gene delivery is a viable approach to achieving systemic transduction of striated musculature in mammals approaching the dimensions of newborn humans.

Original languageEnglish
Pages (from-to)1427-1433
Number of pages7
JournalMolecular Therapy
Issue number8
Publication statusPublished - 2009
Externally publishedYes

Cite this